PROXIMEXA

This brand name is authorized in Nigeria.

Active ingredients

The drug PROXIMEXA contains one active pharmaceutical ingredient (API):

1
UNII Z49QDT0J8Z - CEFUROXIME AXETIL
 

Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.
 
Read more about Cefuroxime

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-5555 Tablet Proximexa 500mg Tablets TAB 500 mg Proximexa 500mg Tablets A4-5555 Proximexa 500mg Tablets Cefuroxime Axetil 500mg, Croscarmellose sodium Type A 80mg, Cellulose microcrystalline 190.060mg, Colloidal anhydrous Silica 2.500mg, Sodium lauryl sulphate 9mg, Vegetable Oil hydrogenated 17mg, Opaspray M-1-7120J White coat 5.06mg, Propyl Parahydroxybenzoate coat 0.150mg, Methylhydroxypropyl Cellulose coat 18.5mg, Propylene glycol coat 1.110mg, , Methyl Parahydroxybenzoate coat 0.180mg. Prescription Only Medicine (POM) Allen AND Hansbury Pharmaceutical Nigeria Ltd, 49, Town planning way, Ilupeju, Lagos, Nigeria. Glaxo Operations UK, Ltd, (trading as Glaxo Wellcome Operations) Harmire Road Barnard Castle County Durham DL12 8DT United Kingdom, Glaxo Operations UK, Ltd, (trading as Glaxo Wellcome Operations) Harmire Road Barnard Castle County Durham DL12 8DT United Kingdom, United Kingdom 2/23/2023 2/22/2028 23/02/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J01DC02 Cefuroxime J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DC Second-generation cephalosporins
Discover more medicines within J01DC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-5555

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈